Modeling disease progression with longitudinal markers

Lurdes Y.T. Inoue, Ruth Etzioni, Christopher Morrell, Peter Müller

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In this article we propose a Bayesian natural history model for disease progression based on the joint modeling of longitudinal biomarker levels, age at clinical detection of disease, and disease status at diagnosis. We establish a link between the longitudinal responses and the natural history of the disease by using an underlying latent disease process that describes the onset of the disease and models the transition to an advanced stage of the disease as dependent on the biomarker levels. We apply our model to data from the Baltimore Longitudinal Study of Aging on prostate-specific antigen to investigate the natural history of prostate cancer.

Original languageEnglish (US)
Pages (from-to)259-270
Number of pages12
JournalJournal of the American Statistical Association
Volume103
Issue number481
DOIs
StatePublished - Mar 1 2008
Externally publishedYes

Fingerprint

Progression
Modeling
Biomarkers
Joint Modeling
Prostate Cancer
Longitudinal Study
Model
Dependent
History

Keywords

  • Disease progression
  • Latent variables
  • Longitudinal response
  • Markov chain Monte Carlo methods
  • Natural history model
  • Prostate-specific antigen

ASJC Scopus subject areas

  • Statistics and Probability
  • Statistics, Probability and Uncertainty

Cite this

Modeling disease progression with longitudinal markers. / Inoue, Lurdes Y.T.; Etzioni, Ruth; Morrell, Christopher; Müller, Peter.

In: Journal of the American Statistical Association, Vol. 103, No. 481, 01.03.2008, p. 259-270.

Research output: Contribution to journalArticle

Inoue, Lurdes Y.T. ; Etzioni, Ruth ; Morrell, Christopher ; Müller, Peter. / Modeling disease progression with longitudinal markers. In: Journal of the American Statistical Association. 2008 ; Vol. 103, No. 481. pp. 259-270.
@article{0e19aab800294992a926f50ab9720336,
title = "Modeling disease progression with longitudinal markers",
abstract = "In this article we propose a Bayesian natural history model for disease progression based on the joint modeling of longitudinal biomarker levels, age at clinical detection of disease, and disease status at diagnosis. We establish a link between the longitudinal responses and the natural history of the disease by using an underlying latent disease process that describes the onset of the disease and models the transition to an advanced stage of the disease as dependent on the biomarker levels. We apply our model to data from the Baltimore Longitudinal Study of Aging on prostate-specific antigen to investigate the natural history of prostate cancer.",
keywords = "Disease progression, Latent variables, Longitudinal response, Markov chain Monte Carlo methods, Natural history model, Prostate-specific antigen",
author = "Inoue, {Lurdes Y.T.} and Ruth Etzioni and Christopher Morrell and Peter M{\"u}ller",
year = "2008",
month = "3",
day = "1",
doi = "10.1198/016214507000000356",
language = "English (US)",
volume = "103",
pages = "259--270",
journal = "Journal of the American Statistical Association",
issn = "0162-1459",
publisher = "Taylor and Francis Ltd.",
number = "481",

}

TY - JOUR

T1 - Modeling disease progression with longitudinal markers

AU - Inoue, Lurdes Y.T.

AU - Etzioni, Ruth

AU - Morrell, Christopher

AU - Müller, Peter

PY - 2008/3/1

Y1 - 2008/3/1

N2 - In this article we propose a Bayesian natural history model for disease progression based on the joint modeling of longitudinal biomarker levels, age at clinical detection of disease, and disease status at diagnosis. We establish a link between the longitudinal responses and the natural history of the disease by using an underlying latent disease process that describes the onset of the disease and models the transition to an advanced stage of the disease as dependent on the biomarker levels. We apply our model to data from the Baltimore Longitudinal Study of Aging on prostate-specific antigen to investigate the natural history of prostate cancer.

AB - In this article we propose a Bayesian natural history model for disease progression based on the joint modeling of longitudinal biomarker levels, age at clinical detection of disease, and disease status at diagnosis. We establish a link between the longitudinal responses and the natural history of the disease by using an underlying latent disease process that describes the onset of the disease and models the transition to an advanced stage of the disease as dependent on the biomarker levels. We apply our model to data from the Baltimore Longitudinal Study of Aging on prostate-specific antigen to investigate the natural history of prostate cancer.

KW - Disease progression

KW - Latent variables

KW - Longitudinal response

KW - Markov chain Monte Carlo methods

KW - Natural history model

KW - Prostate-specific antigen

UR - http://www.scopus.com/inward/record.url?scp=42349097208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42349097208&partnerID=8YFLogxK

U2 - 10.1198/016214507000000356

DO - 10.1198/016214507000000356

M3 - Article

VL - 103

SP - 259

EP - 270

JO - Journal of the American Statistical Association

JF - Journal of the American Statistical Association

SN - 0162-1459

IS - 481

ER -